

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.74033978 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.74033978 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.41705728 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.41705728 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 5.00110457 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.00110457 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.57281363 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.39464426 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 4.17838100 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.11997549 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09960697 |
| 12 | signal peptide processing (GO:0006465) | 4.08259498 |
| 13 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.92187709 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.90134125 |
| 15 | protein carboxylation (GO:0018214) | 3.90134125 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 3.89367420 |
| 17 | valine metabolic process (GO:0006573) | 3.84799847 |
| 18 | glyoxylate metabolic process (GO:0046487) | 3.80359348 |
| 19 | bile acid biosynthetic process (GO:0006699) | 3.77844447 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.73309554 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.71442896 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64573124 |
| 23 | protein retention in ER lumen (GO:0006621) | 3.60947289 |
| 24 | regulation of protein activation cascade (GO:2000257) | 3.58814788 |
| 25 | tryptophan catabolic process (GO:0006569) | 3.58723669 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 3.58723669 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 3.58723669 |
| 28 | tyrosine metabolic process (GO:0006570) | 3.56973321 |
| 29 | tryptophan metabolic process (GO:0006568) | 3.55472652 |
| 30 | * thyroid hormone generation (GO:0006590) | 3.55385876 |
| 31 | fatty acid beta-oxidation (GO:0006635) | 3.49203209 |
| 32 | regulation of complement activation (GO:0030449) | 3.46592848 |
| 33 | COPII vesicle coating (GO:0048208) | 3.46363020 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46305422 |
| 35 | negative regulation of complement activation (GO:0045916) | 3.39712171 |
| 36 | cysteine metabolic process (GO:0006534) | 3.39287054 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 3.38821949 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.37017220 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.36592997 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 3.36301832 |
| 41 | bile acid metabolic process (GO:0008206) | 3.35422836 |
| 42 | fatty acid oxidation (GO:0019395) | 3.31766741 |
| 43 | reverse cholesterol transport (GO:0043691) | 3.31378642 |
| 44 | lipid oxidation (GO:0034440) | 3.30891544 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.28911621 |
| 46 | aromatic amino acid family metabolic process (GO:0009072) | 3.28090506 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 3.25755891 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 3.25508052 |
| 49 | macromolecular complex remodeling (GO:0034367) | 3.25508052 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25508052 |
| 51 | lysine catabolic process (GO:0006554) | 3.24966116 |
| 52 | lysine metabolic process (GO:0006553) | 3.24966116 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.24501058 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.23747902 |
| 55 | fatty acid catabolic process (GO:0009062) | 3.23591663 |
| 56 | drug transmembrane transport (GO:0006855) | 3.23501645 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.18651709 |
| 58 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18651709 |
| 59 | peptide hormone processing (GO:0016486) | 3.18473858 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.18468421 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 3.17263585 |
| 62 | tricarboxylic acid metabolic process (GO:0072350) | 3.17188480 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 3.12144799 |
| 64 | regulation of cholesterol metabolic process (GO:0090181) | 3.10847356 |
| 65 | cellular extravasation (GO:0045123) | 3.10618515 |
| 66 | urea cycle (GO:0000050) | 3.10205612 |
| 67 | urea metabolic process (GO:0019627) | 3.10205612 |
| 68 | phospholipid efflux (GO:0033700) | 3.09758183 |
| 69 | monocarboxylic acid catabolic process (GO:0072329) | 3.09523244 |
| 70 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.07481642 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06000743 |
| 72 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04912170 |
| 73 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04912170 |
| 74 | modulation by symbiont of host immune response (GO:0052553) | 3.04912170 |
| 75 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04912170 |
| 76 | modulation by symbiont of host defense response (GO:0052031) | 3.04912170 |
| 77 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04912170 |
| 78 | neutrophil activation (GO:0042119) | 3.04786991 |
| 79 | detection of external biotic stimulus (GO:0098581) | 3.04460015 |
| 80 | microglial cell activation (GO:0001774) | 3.03484785 |
| 81 | opsonization (GO:0008228) | 3.01735262 |
| 82 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.00351975 |
| 83 | branched-chain amino acid metabolic process (GO:0009081) | 2.98167011 |
| 84 | sequestering of metal ion (GO:0051238) | 2.97394074 |
| 85 | bile acid and bile salt transport (GO:0015721) | 2.96050803 |
| 86 | regulation of plasminogen activation (GO:0010755) | 2.95352788 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 2.94028425 |
| 88 | branched-chain amino acid catabolic process (GO:0009083) | 2.93894174 |
| 89 | * thyroid hormone metabolic process (GO:0042403) | 2.92971182 |
| 90 | acylglycerol homeostasis (GO:0055090) | 2.92543192 |
| 91 | triglyceride homeostasis (GO:0070328) | 2.92543192 |
| 92 | nitrogen cycle metabolic process (GO:0071941) | 2.92198159 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 2.92115637 |
| 94 | macrophage activation (GO:0042116) | 2.90920333 |
| 95 | toxin metabolic process (GO:0009404) | 2.89738411 |
| 96 | alpha-amino acid catabolic process (GO:1901606) | 2.89660206 |
| 97 | urate metabolic process (GO:0046415) | 2.89091330 |
| 98 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89089650 |
| 99 | detection of other organism (GO:0098543) | 2.87842584 |
| 100 | granulocyte activation (GO:0036230) | 2.86756478 |
| 101 | coenzyme catabolic process (GO:0009109) | 2.84843250 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84539626 |
| 103 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84539626 |
| 104 | endocrine pancreas development (GO:0031018) | 2.84271253 |
| 105 | cellular amino acid catabolic process (GO:0009063) | 2.82617037 |
| 106 | organic acid catabolic process (GO:0016054) | 2.81538904 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 2.81538904 |
| 108 | negative regulation of interleukin-12 production (GO:0032695) | 2.80202848 |
| 109 | ketone body metabolic process (GO:1902224) | 2.79372011 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.78541994 |
| 111 | amine catabolic process (GO:0009310) | 2.77864199 |
| 112 | cellular biogenic amine catabolic process (GO:0042402) | 2.77864199 |
| 113 | cellular modified amino acid catabolic process (GO:0042219) | 2.77382170 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 2.74927606 |
| 115 | indolalkylamine metabolic process (GO:0006586) | 2.74247670 |
| 116 | response to peptidoglycan (GO:0032494) | 2.74028345 |
| 117 | plasma lipoprotein particle clearance (GO:0034381) | 2.73446241 |
| 118 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.71408379 |
| 119 | lipoprotein metabolic process (GO:0042157) | 2.70716228 |
| 120 | drug transport (GO:0015893) | 2.70086001 |
| 121 | carnitine metabolic process (GO:0009437) | 2.70074204 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68619597 |
| 123 | ethanol oxidation (GO:0006069) | 2.68128186 |
| 124 | blood coagulation, intrinsic pathway (GO:0007597) | 2.66701005 |
| 125 | negative regulation of digestive system process (GO:0060457) | 2.65323172 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 2.65267028 |
| 127 | keratan sulfate catabolic process (GO:0042340) | 2.64799948 |
| 128 | drug metabolic process (GO:0017144) | 2.64166660 |
| 129 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64117640 |
| 130 | positive regulation of glycolytic process (GO:0045821) | 2.64116830 |
| 131 | protein activation cascade (GO:0072376) | 2.64085285 |
| 132 | detection of biotic stimulus (GO:0009595) | 2.60562721 |
| 133 | detection of bacterium (GO:0016045) | 2.56360143 |
| 134 | myeloid cell activation involved in immune response (GO:0002275) | 2.51531003 |
| 135 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48312619 |
| 136 | cellular response to ethanol (GO:0071361) | 2.47864079 |
| 137 | oxygen transport (GO:0015671) | 2.47121600 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.46479757 |
| 139 | positive regulation of mast cell activation (GO:0033005) | 2.42050648 |
| 140 | xenobiotic catabolic process (GO:0042178) | 2.40607054 |
| 141 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.40399230 |
| 142 | regulation of mast cell degranulation (GO:0043304) | 2.36481041 |
| 143 | regulation of mast cell activation (GO:0033003) | 2.36409270 |
| 144 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.35588362 |
| 145 | cellular response to zinc ion (GO:0071294) | 2.33287232 |
| 146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.32871478 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.31073515 |
| 148 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.26693008 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.26173426 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.26173426 |
| 151 | response to type I interferon (GO:0034340) | 2.25899815 |
| 152 | regulation of platelet activation (GO:0010543) | 2.24401774 |
| 153 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.22568787 |
| 154 | neutrophil mediated immunity (GO:0002446) | 2.22321191 |
| 155 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21569255 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.20375607 |
| 157 | response to host immune response (GO:0052572) | 2.20375607 |
| 158 | regulation of platelet aggregation (GO:0090330) | 2.20241488 |
| 159 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.19195872 |
| 160 | positive regulation of mast cell degranulation (GO:0043306) | 2.19195872 |
| 161 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.18475712 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.18475712 |
| 163 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.18441479 |
| 164 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.17730152 |
| 165 | negative regulation of interleukin-8 production (GO:0032717) | 2.17277295 |
| 166 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.16806343 |
| 167 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.16318560 |
| 168 | positive regulation of receptor recycling (GO:0001921) | 2.14065867 |
| 169 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.13931591 |
| 170 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.13771788 |
| 171 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.13030598 |
| 172 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.12875398 |
| 173 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.12020983 |
| 174 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.10112878 |
| 175 | regulation of antigen processing and presentation (GO:0002577) | 2.08799522 |
| 176 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.08478058 |
| 177 | regulation of leukocyte degranulation (GO:0043300) | 2.07495196 |
| 178 | positive regulation of blood coagulation (GO:0030194) | 2.06945339 |
| 179 | positive regulation of hemostasis (GO:1900048) | 2.06945339 |
| 180 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.06846862 |
| 181 | T-helper 1 type immune response (GO:0042088) | 2.06786332 |
| 182 | positive regulation of coagulation (GO:0050820) | 2.05899786 |
| 183 | dendritic cell migration (GO:0036336) | 2.05786840 |
| 184 | myeloid leukocyte activation (GO:0002274) | 2.05031188 |
| 185 | phagocytosis, engulfment (GO:0006911) | 2.04678089 |
| 186 | neutrophil chemotaxis (GO:0030593) | 2.03699140 |
| 187 | superoxide anion generation (GO:0042554) | 2.02643203 |
| 188 | germinal center formation (GO:0002467) | 2.02067718 |
| 189 | angiogenesis involved in wound healing (GO:0060055) | 2.01638755 |
| 190 | positive regulation of tumor necrosis factor production (GO:0032760) | 1.99864612 |
| 191 | neutrophil migration (GO:1990266) | 1.98792173 |
| 192 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.97626888 |
| 193 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.97322139 |
| 194 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 1.97198163 |
| 195 | response to host defenses (GO:0052200) | 1.97198163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.32326409 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.15229406 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.14101596 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.93684988 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.71172988 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17791048 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.95265804 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.62883784 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.61118825 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.59669531 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.37125259 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.24431334 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.15497866 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82954047 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.65899466 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.63984037 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62209645 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32058601 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.09939968 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07732991 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04733291 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.91509041 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78118534 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77644859 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74263272 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.70228190 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67899392 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.66230692 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64855239 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62082505 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61482558 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56707154 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56174548 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55437326 |
| 35 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51992913 |
| 36 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45504429 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44550805 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40027458 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38280580 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36072167 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32261521 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30811955 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25108102 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25075863 |
| 45 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24305183 |
| 46 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23992519 |
| 47 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22128115 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20687960 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20046352 |
| 50 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17590654 |
| 51 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17446130 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.17210397 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17176414 |
| 54 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17064663 |
| 55 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16207392 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16162797 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15119643 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14349698 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14349698 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13439184 |
| 61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13046338 |
| 62 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12934984 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11373686 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10573115 |
| 65 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09371963 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09314512 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07952052 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07086467 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05344988 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03776547 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03418105 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02679461 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02375013 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01936433 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99959324 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99632557 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99040429 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98577273 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97741333 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97384637 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96615709 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96165480 |
| 83 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95994021 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95140727 |
| 85 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94467139 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93809191 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93245517 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93082404 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92924554 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92656051 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91470071 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91220668 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90197263 |
| 94 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89707221 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89357499 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88639307 |
| 97 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88637349 |
| 98 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.88506404 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88129598 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87586438 |
| 101 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85626459 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84957862 |
| 103 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84299402 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83776123 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83413804 |
| 106 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82977409 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 0.82722567 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82394945 |
| 109 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82106505 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81254973 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81107116 |
| 112 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81087730 |
| 113 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80155794 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.80064889 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.79684198 |
| 116 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.79453796 |
| 117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.79397675 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78957960 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78267200 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77792091 |
| 121 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76646589 |
| 122 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76035705 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75902085 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75431781 |
| 125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74597961 |
| 126 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.74198266 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.73734129 |
| 128 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.71618736 |
| 129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70851348 |
| 130 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70729323 |
| 131 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.70018915 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69179597 |
| 133 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68737438 |
| 134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.66407815 |
| 135 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65830084 |
| 136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.65050913 |
| 137 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.65050913 |
| 138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64706494 |
| 139 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.64525776 |
| 140 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.62416906 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61828060 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.61465277 |
| 143 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.61038654 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60694499 |
| 145 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.60564073 |
| 146 | GATA3_26560356_Chip-Seq_TH2_Human | 0.60541183 |
| 147 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58999300 |
| 148 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.58884234 |
| 149 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.58701615 |
| 150 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58640327 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58228698 |
| 152 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58139649 |
| 153 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58135603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.26033374 |
| 2 | MP0005365_abnormal_bile_salt | 4.59532008 |
| 3 | MP0005360_urolithiasis | 4.22930918 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.81161155 |
| 5 | MP0003195_calcinosis | 3.80233715 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23809079 |
| 7 | MP0003252_abnormal_bile_duct | 2.88784458 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.73054479 |
| 9 | MP0006082_CNS_inflammation | 2.65218771 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.48205910 |
| 11 | MP0003303_peritoneal_inflammation | 2.44847788 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.41166768 |
| 13 | MP0005332_abnormal_amino_acid | 2.37207563 |
| 14 | MP0009840_abnormal_foam_cell | 2.32144832 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.30881368 |
| 16 | MP0003436_decreased_susceptibility_to | 2.30174311 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.28380748 |
| 18 | MP0004043_abnormal_pH_regulation | 2.25487423 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.08278092 |
| 20 | MP0002419_abnormal_innate_immunity | 2.07391094 |
| 21 | MP0009785_altered_susceptibility_to | 2.06337447 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.03436615 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.98485711 |
| 24 | MP0005379_endocrine/exocrine_gland_phen | 1.97961353 |
| 25 | MP0003868_abnormal_feces_composition | 1.96137468 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.94709677 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.93645354 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.89281728 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.87516676 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.86807757 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.84713422 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.80594339 |
| 33 | MP0005220_abnormal_exocrine_pancreas | 1.78327057 |
| 34 | MP0001958_emphysema | 1.77434063 |
| 35 | MP0008438_abnormal_cutaneous_collagen | 1.74715983 |
| 36 | MP0005025_abnormal_response_to | 1.72158537 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.71689232 |
| 38 | MP0005387_immune_system_phenotype | 1.69227778 |
| 39 | MP0001790_abnormal_immune_system | 1.69227778 |
| 40 | MP0000678_abnormal_parathyroid_gland | 1.67420630 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.63751157 |
| 42 | MP0005083_abnormal_biliary_tract | 1.63187086 |
| 43 | MP0001944_abnormal_pancreas_morphology | 1.62492612 |
| 44 | MP0000343_altered_response_to | 1.59274748 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.58272044 |
| 46 | MP0005319_abnormal_enzyme/_coenzyme | 1.58146183 |
| 47 | MP0005670_abnormal_white_adipose | 1.57766820 |
| 48 | MP0000609_abnormal_liver_physiology | 1.57690592 |
| 49 | MP0002693_abnormal_pancreas_physiology | 1.52215141 |
| 50 | MP0005164_abnormal_response_to | 1.50968244 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.49666425 |
| 52 | MP0000604_amyloidosis | 1.49223459 |
| 53 | MP0001756_abnormal_urination | 1.49068412 |
| 54 | MP0003075_altered_response_to | 1.48952486 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.48868784 |
| 56 | MP0004883_abnormal_blood_vessel | 1.47974950 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.46246433 |
| 58 | MP0001764_abnormal_homeostasis | 1.45211497 |
| 59 | MP0003045_fibrosis | 1.45040991 |
| 60 | MP0006054_spinal_hemorrhage | 1.42568459 |
| 61 | MP0002078_abnormal_glucose_homeostasis | 1.41322075 |
| 62 | MP0002723_abnormal_immune_serum | 1.40826218 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39611945 |
| 64 | MP0003724_increased_susceptibility_to | 1.39321964 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.38455946 |
| 66 | MP0001800_abnormal_humoral_immune | 1.38094011 |
| 67 | MP0003186_abnormal_redox_activity | 1.37866348 |
| 68 | MP0003828_pulmonary_edema | 1.37049658 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.36286406 |
| 70 | MP0001845_abnormal_inflammatory_respons | 1.35172181 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.34549883 |
| 72 | MP0000681_abnormal_thyroid_gland | 1.34067079 |
| 73 | MP0008004_abnormal_stomach_pH | 1.32308299 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.30968840 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.30381464 |
| 76 | MP0005671_abnormal_response_to | 1.25612224 |
| 77 | MP0002876_abnormal_thyroid_physiology | 1.24853609 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.22158405 |
| 79 | MP0009697_abnormal_copulation | 1.21197116 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.16986907 |
| 81 | MP0001819_abnormal_immune_cell | 1.15746763 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 1.15544423 |
| 83 | MP0000003_abnormal_adipose_tissue | 1.13860581 |
| 84 | MP0008260_abnormal_autophagy | 1.09895963 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.09762152 |
| 86 | MP0000230_abnormal_systemic_arterial | 1.09731637 |
| 87 | MP0002405_respiratory_system_inflammati | 1.07580167 |
| 88 | MP0002132_abnormal_respiratory_system | 1.07085234 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 1.06804601 |
| 90 | MP0008469_abnormal_protein_level | 1.06598636 |
| 91 | MP0001542_abnormal_bone_strength | 1.05122872 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 1.04984769 |
| 93 | MP0001765_abnormal_ion_homeostasis | 1.04912265 |
| 94 | MP0005310_abnormal_salivary_gland | 1.03358405 |
| 95 | MP0003300_gastrointestinal_ulcer | 1.02355934 |
| 96 | MP0004510_myositis | 1.02175306 |
| 97 | MP0004147_increased_porphyrin_level | 0.98741598 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 0.98684708 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.98287341 |
| 100 | MP0002928_abnormal_bile_duct | 0.96553833 |
| 101 | MP0000249_abnormal_blood_vessel | 0.96519294 |
| 102 | MP0005390_skeleton_phenotype | 0.95457389 |
| 103 | MP0005397_hematopoietic_system_phenotyp | 0.93895154 |
| 104 | MP0001545_abnormal_hematopoietic_system | 0.93895154 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.93004376 |
| 106 | MP0004130_abnormal_muscle_cell | 0.92597242 |
| 107 | MP0005166_decreased_susceptibility_to | 0.90170984 |
| 108 | MP0002933_joint_inflammation | 0.90083243 |
| 109 | MP0001851_eye_inflammation | 0.89495930 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.89060818 |
| 111 | MP0000598_abnormal_liver_morphology | 0.88802652 |
| 112 | MP0009764_decreased_sensitivity_to | 0.88395114 |
| 113 | MP0004947_skin_inflammation | 0.87850913 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.87278164 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.87274564 |
| 116 | MP0003953_abnormal_hormone_level | 0.86978559 |
| 117 | MP0003329_amyloid_beta_deposits | 0.86442764 |
| 118 | MP0005408_hypopigmentation | 0.86044850 |
| 119 | MP0003879_abnormal_hair_cell | 0.85178479 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.85124718 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.83897483 |
| 122 | MP0003011_delayed_dark_adaptation | 0.83265650 |
| 123 | MP0005334_abnormal_fat_pad | 0.82555937 |
| 124 | MP0000920_abnormal_myelination | 0.82174183 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.82059017 |
| 126 | MP0003959_abnormal_lean_body | 0.81583889 |
| 127 | MP0005503_abnormal_tendon_morphology | 0.80620392 |
| 128 | MP0005275_abnormal_skin_tensile | 0.80601462 |
| 129 | MP0005174_abnormal_tail_pigmentation | 0.79707460 |
| 130 | MP0003866_abnormal_defecation | 0.79148470 |
| 131 | MP0009763_increased_sensitivity_to | 0.78778503 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.78729023 |
| 133 | MP0001879_abnormal_lymphatic_vessel | 0.78624737 |
| 134 | MP0005171_absent_coat_pigmentation | 0.78111055 |
| 135 | MP0005375_adipose_tissue_phenotype | 0.77224657 |
| 136 | MP0001270_distended_abdomen | 0.77137368 |
| 137 | MP0001661_extended_life_span | 0.76990219 |
| 138 | MP0000685_abnormal_immune_system | 0.76149614 |
| 139 | MP0005535_abnormal_body_temperature | 0.75838099 |
| 140 | MP0003795_abnormal_bone_structure | 0.74502418 |
| 141 | MP0002295_abnormal_pulmonary_circulatio | 0.73789557 |
| 142 | MP0003279_aneurysm | 0.73733989 |
| 143 | MP0000371_diluted_coat_color | 0.73299776 |
| 144 | MP0005451_abnormal_body_composition | 0.73117178 |
| 145 | MP0003690_abnormal_glial_cell | 0.72632103 |
| 146 | MP0002254_reproductive_system_inflammat | 0.72453738 |
| 147 | MP0005464_abnormal_platelet_physiology | 0.70517906 |
| 148 | MP0002896_abnormal_bone_mineralization | 0.69065910 |
| 149 | MP0002060_abnormal_skin_morphology | 0.67364125 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.65700434 |
| 151 | MP0004272_abnormal_basement_membrane | 0.65160594 |
| 152 | MP0002168_other_aberrant_phenotype | 0.64787990 |
| 153 | MP0001835_abnormal_antigen_presentation | 0.64647595 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.64140928 |
| 155 | MP0000613_abnormal_salivary_gland | 0.63729805 |
| 156 | MP0001853_heart_inflammation | 0.62205628 |
| 157 | MP0003638_abnormal_response/metabolism_ | 0.61757366 |
| 158 | MP0005448_abnormal_energy_balance | 0.61695084 |
| 159 | MP0002971_abnormal_brown_adipose | 0.60395279 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.92972912 |
| 2 | Hypoglycemic coma (HP:0001325) | 5.68229145 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.48342601 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.45312567 |
| 5 | Ketoacidosis (HP:0001993) | 4.44549507 |
| 6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.32851763 |
| 7 | Generalized aminoaciduria (HP:0002909) | 4.26109223 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.08389055 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.08041677 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.08041677 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.08041677 |
| 12 | Ketosis (HP:0001946) | 3.98363195 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.97075080 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 3.92973585 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90626622 |
| 16 | Xanthomatosis (HP:0000991) | 3.84369855 |
| 17 | Orchitis (HP:0100796) | 3.79209739 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.77252119 |
| 19 | Late onset (HP:0003584) | 3.72420732 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.72079880 |
| 21 | Myositis (HP:0100614) | 3.67927148 |
| 22 | Symptomatic seizures (HP:0011145) | 3.67054285 |
| 23 | Complement deficiency (HP:0004431) | 3.65312514 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.61693844 |
| 25 | Optic neuritis (HP:0100653) | 3.61693844 |
| 26 | Recurrent abscess formation (HP:0002722) | 3.56181418 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.51844341 |
| 28 | Stomatitis (HP:0010280) | 3.51796224 |
| 29 | Hyperlipoproteinemia (HP:0010980) | 3.48745758 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.46793402 |
| 31 | Gingival bleeding (HP:0000225) | 3.41844722 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39126584 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36866982 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.31851038 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24363170 |
| 36 | Spontaneous hematomas (HP:0007420) | 3.21175829 |
| 37 | Hyperglycemia (HP:0003074) | 3.15385033 |
| 38 | Purpura (HP:0000979) | 3.08582409 |
| 39 | Peritonitis (HP:0002586) | 3.00063866 |
| 40 | Loss of speech (HP:0002371) | 2.99616893 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.99005189 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.99005189 |
| 43 | Hematochezia (HP:0002573) | 2.95046197 |
| 44 | Joint hemorrhage (HP:0005261) | 2.95016452 |
| 45 | Large for gestational age (HP:0001520) | 2.87225030 |
| 46 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.84994508 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.84994508 |
| 48 | Hyperammonemia (HP:0001987) | 2.84197100 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.80744707 |
| 50 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.80730438 |
| 51 | Increased CSF protein (HP:0002922) | 2.80435876 |
| 52 | Fat malabsorption (HP:0002630) | 2.79614748 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.79024303 |
| 54 | Epistaxis (HP:0000421) | 2.78531644 |
| 55 | Hyperglycinuria (HP:0003108) | 2.77272746 |
| 56 | Amyloidosis (HP:0011034) | 2.75753952 |
| 57 | Increased cerebral lipofuscin (HP:0011813) | 2.74110413 |
| 58 | Episodic fever (HP:0001954) | 2.73586618 |
| 59 | Hyperbilirubinemia (HP:0002904) | 2.71648807 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.71455055 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.71455055 |
| 62 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70126750 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70126750 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70126750 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.69897015 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69676881 |
| 67 | Abnormality of complement system (HP:0005339) | 2.65562692 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.62823113 |
| 69 | Epidermoid cyst (HP:0200040) | 2.58875551 |
| 70 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58701143 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.54241073 |
| 72 | Petechiae (HP:0000967) | 2.53267982 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.47466228 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.43598073 |
| 75 | Gingivitis (HP:0000230) | 2.41034550 |
| 76 | Hemoptysis (HP:0002105) | 2.40178135 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.39148127 |
| 78 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38701663 |
| 79 | Abnormality of glycine metabolism (HP:0010895) | 2.38701663 |
| 80 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.38325983 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37407944 |
| 82 | Skin nodule (HP:0200036) | 2.36889701 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.34985350 |
| 84 | Pulmonary embolism (HP:0002204) | 2.34760021 |
| 85 | Hyperglycinemia (HP:0002154) | 2.33905169 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.33860898 |
| 87 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32321284 |
| 88 | Abnormality of methionine metabolism (HP:0010901) | 2.32275526 |
| 89 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.32178065 |
| 90 | Recurrent skin infections (HP:0001581) | 2.32085064 |
| 91 | Hypolipoproteinemia (HP:0010981) | 2.30491505 |
| 92 | Hypoalphalipoproteinemia (HP:0003233) | 2.30182360 |
| 93 | Metabolic acidosis (HP:0001942) | 2.27750077 |
| 94 | Hypothermia (HP:0002045) | 2.27067285 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.27019983 |
| 96 | Arthropathy (HP:0003040) | 2.25185754 |
| 97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24472454 |
| 98 | Gout (HP:0001997) | 2.19426119 |
| 99 | Abnormal hemoglobin (HP:0011902) | 2.19419592 |
| 100 | Abnormality of purine metabolism (HP:0004352) | 2.19353172 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 2.18599694 |
| 102 | Glycosuria (HP:0003076) | 2.18599694 |
| 103 | Arterial thrombosis (HP:0004420) | 2.17222426 |
| 104 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16802526 |
| 105 | Mitral stenosis (HP:0001718) | 2.16114189 |
| 106 | Insulin resistance (HP:0000855) | 2.12097937 |
| 107 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.10567536 |
| 108 | Beaking of vertebral bodies (HP:0004568) | 2.09334032 |
| 109 | Cerebral palsy (HP:0100021) | 2.07659929 |
| 110 | Vasculitis (HP:0002633) | 2.07362721 |
| 111 | Steatorrhea (HP:0002570) | 2.07105540 |
| 112 | Pancreatitis (HP:0001733) | 2.06231212 |
| 113 | Progressive neurologic deterioration (HP:0002344) | 2.04429580 |
| 114 | Goiter (HP:0000853) | 2.04146916 |
| 115 | Aortic aneurysm (HP:0004942) | 2.04024686 |
| 116 | Abnormal platelet volume (HP:0011876) | 2.02042750 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 2.01405058 |
| 118 | Hypercholesterolemia (HP:0003124) | 2.01288593 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 2.01030287 |
| 120 | Joint swelling (HP:0001386) | 2.00832006 |
| 121 | Renal cortical cysts (HP:0000803) | 2.00563111 |
| 122 | Acne (HP:0001061) | 1.98910532 |
| 123 | Irritability (HP:0000737) | 1.98027604 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97771078 |
| 125 | Nephritis (HP:0000123) | 1.97016983 |
| 126 | Glomerulonephritis (HP:0000099) | 1.96086350 |
| 127 | Recurrent fungal infections (HP:0002841) | 1.95383798 |
| 128 | Abnormality of T cell number (HP:0011839) | 1.95226442 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94789041 |
| 130 | Obstructive lung disease (HP:0006536) | 1.94789041 |
| 131 | Myocardial infarction (HP:0001658) | 1.93332574 |
| 132 | Hepatic necrosis (HP:0002605) | 1.93242101 |
| 133 | Retinal atrophy (HP:0001105) | 1.92588493 |
| 134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91824967 |
| 135 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91603697 |
| 136 | T lymphocytopenia (HP:0005403) | 1.91146435 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 1.90752075 |
| 138 | Spondylolisthesis (HP:0003302) | 1.90327899 |
| 139 | Bruising susceptibility (HP:0000978) | 1.89017855 |
| 140 | Polycythemia (HP:0001901) | 1.88988860 |
| 141 | Enlarged kidneys (HP:0000105) | 1.88254119 |
| 142 | Abnormality of the pericardium (HP:0001697) | 1.88237571 |
| 143 | Hypophosphatemia (HP:0002148) | 1.87495168 |
| 144 | Albinism (HP:0001022) | 1.87084695 |
| 145 | Asymmetric septal hypertrophy (HP:0001670) | 1.84977625 |
| 146 | Lethargy (HP:0001254) | 1.84937290 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.83995760 |
| 148 | Protrusio acetabuli (HP:0003179) | 1.81891121 |
| 149 | Aortic dissection (HP:0002647) | 1.81212620 |
| 150 | Protuberant abdomen (HP:0001538) | 1.80994284 |
| 151 | Bone cyst (HP:0012062) | 1.80605274 |
| 152 | Growth hormone excess (HP:0000845) | 1.79640634 |
| 153 | Cervical subluxation (HP:0003308) | 1.78735255 |
| 154 | Abnormality of iron homeostasis (HP:0011031) | 1.78050643 |
| 155 | Gangrene (HP:0100758) | 1.77119514 |
| 156 | Alkalosis (HP:0001948) | 1.76643347 |
| 157 | Chest pain (HP:0100749) | 1.76576830 |
| 158 | Microcytic anemia (HP:0001935) | 1.75630870 |
| 159 | Hyperphosphatemia (HP:0002905) | 1.75256408 |
| 160 | Menorrhagia (HP:0000132) | 1.75078865 |
| 161 | Nausea (HP:0002018) | 1.74005419 |
| 162 | Conjunctival telangiectasia (HP:0000524) | 1.73793487 |
| 163 | Vomiting (HP:0002013) | 1.73537053 |
| 164 | Abnormal protein glycosylation (HP:0012346) | 1.73474861 |
| 165 | Abnormal glycosylation (HP:0012345) | 1.73474861 |
| 166 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.73474861 |
| 167 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.73474861 |
| 168 | Hydroxyprolinuria (HP:0003080) | 1.73462530 |
| 169 | Abnormality of proline metabolism (HP:0010907) | 1.73462530 |
| 170 | Basal ganglia calcification (HP:0002135) | 1.73119474 |
| 171 | Vertigo (HP:0002321) | 1.72224438 |
| 172 | Nuclear cataract (HP:0100018) | 1.71676343 |
| 173 | Encephalitis (HP:0002383) | 1.71255356 |
| 174 | Malnutrition (HP:0004395) | 1.70249383 |
| 175 | Cardiovascular calcification (HP:0011915) | 1.67685513 |
| 176 | Vascular tortuosity (HP:0004948) | 1.66294742 |
| 177 | Leukocytosis (HP:0001974) | 1.66207303 |
| 178 | Urticaria (HP:0001025) | 1.65747806 |
| 179 | Neurofibrillary tangles (HP:0002185) | 1.65608038 |
| 180 | Anorexia (HP:0002039) | 1.64949603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.71478148 |
| 2 | MAPK15 | 4.68459181 |
| 3 | BCKDK | 3.80592366 |
| 4 | ERN1 | 3.57648397 |
| 5 | PIK3CG | 3.51908707 |
| 6 | TAOK3 | 3.31044358 |
| 7 | FRK | 3.23220245 |
| 8 | RIPK4 | 3.07030609 |
| 9 | BLK | 2.69751595 |
| 10 | FLT3 | 2.62242416 |
| 11 | WNK3 | 2.60480596 |
| 12 | WNK4 | 2.20375948 |
| 13 | SIK1 | 2.10124089 |
| 14 | TNIK | 1.84512792 |
| 15 | TIE1 | 1.82899662 |
| 16 | PRKD3 | 1.80173984 |
| 17 | TGFBR2 | 1.75175020 |
| 18 | IRAK3 | 1.66889129 |
| 19 | ACVR1B | 1.65140160 |
| 20 | FGFR4 | 1.58431331 |
| 21 | BMPR2 | 1.55311444 |
| 22 | TXK | 1.55063786 |
| 23 | EPHA3 | 1.53227452 |
| 24 | GRK6 | 1.52627245 |
| 25 | TRIB3 | 1.51561184 |
| 26 | KIT | 1.47861786 |
| 27 | TEC | 1.41644913 |
| 28 | MYLK | 1.38634789 |
| 29 | PTK2B | 1.34091264 |
| 30 | FES | 1.31607088 |
| 31 | DAPK2 | 1.31469509 |
| 32 | PASK | 1.27170262 |
| 33 | TNK2 | 1.26520886 |
| 34 | FGFR3 | 1.24990557 |
| 35 | STK16 | 1.22103873 |
| 36 | SYK | 1.18911236 |
| 37 | FGR | 1.17380524 |
| 38 | MAP4K1 | 1.14509270 |
| 39 | TYK2 | 1.13520120 |
| 40 | HIPK2 | 1.11869738 |
| 41 | CAMKK2 | 1.11224344 |
| 42 | MUSK | 1.09754129 |
| 43 | PRKG2 | 1.09584365 |
| 44 | DDR2 | 1.08949217 |
| 45 | IRAK4 | 1.06555879 |
| 46 | BTK | 1.06540493 |
| 47 | MAP3K13 | 1.06361541 |
| 48 | FER | 1.03710352 |
| 49 | HCK | 1.02374664 |
| 50 | PTK6 | 1.01901479 |
| 51 | PINK1 | 1.00745732 |
| 52 | MAP2K3 | 0.99906687 |
| 53 | IRAK1 | 0.99399396 |
| 54 | NUAK1 | 0.97792684 |
| 55 | ZAP70 | 0.94848873 |
| 56 | TBK1 | 0.93969307 |
| 57 | CDC42BPA | 0.93384532 |
| 58 | KDR | 0.89795154 |
| 59 | MAP3K2 | 0.89194806 |
| 60 | JAK3 | 0.86958476 |
| 61 | JAK1 | 0.84186642 |
| 62 | NEK9 | 0.83702275 |
| 63 | MAP3K1 | 0.83558757 |
| 64 | NLK | 0.82901042 |
| 65 | BRSK2 | 0.82848305 |
| 66 | DYRK1B | 0.82532441 |
| 67 | MAPK7 | 0.82240194 |
| 68 | YES1 | 0.80293141 |
| 69 | PRKAA2 | 0.80128845 |
| 70 | TAOK1 | 0.80117636 |
| 71 | RIPK1 | 0.77990922 |
| 72 | MAP3K12 | 0.77008422 |
| 73 | TGFBR1 | 0.76593112 |
| 74 | PDK1 | 0.75031181 |
| 75 | EIF2AK3 | 0.73297959 |
| 76 | ADRBK1 | 0.72778183 |
| 77 | LCK | 0.72493972 |
| 78 | JAK2 | 0.72237828 |
| 79 | PDGFRB | 0.71619909 |
| 80 | BMPR1B | 0.71131804 |
| 81 | PDPK1 | 0.71013889 |
| 82 | MOS | 0.69880261 |
| 83 | MAPK11 | 0.67726060 |
| 84 | IKBKE | 0.67364545 |
| 85 | MARK3 | 0.67356532 |
| 86 | CDK8 | 0.66746649 |
| 87 | KSR2 | 0.66135021 |
| 88 | PKN2 | 0.66130681 |
| 89 | SGK2 | 0.65219735 |
| 90 | PDGFRA | 0.64153250 |
| 91 | PIK3CA | 0.63528656 |
| 92 | LMTK2 | 0.62535317 |
| 93 | MST1R | 0.61952010 |
| 94 | NME2 | 0.61319400 |
| 95 | MAPKAPK5 | 0.61182634 |
| 96 | PTK2 | 0.60649710 |
| 97 | SCYL2 | 0.60083717 |
| 98 | EPHB1 | 0.59981049 |
| 99 | NTRK3 | 0.59878988 |
| 100 | PRKD1 | 0.59077663 |
| 101 | MAP3K5 | 0.57798644 |
| 102 | STK24 | 0.56754267 |
| 103 | SGK3 | 0.56562563 |
| 104 | MAP3K11 | 0.55187621 |
| 105 | MAP3K6 | 0.54406998 |
| 106 | PIM2 | 0.53931372 |
| 107 | MAP3K14 | 0.53789278 |
| 108 | MAP3K3 | 0.53757828 |
| 109 | MAPK12 | 0.52471665 |
| 110 | GRK1 | 0.52191004 |
| 111 | GRK5 | 0.51926285 |
| 112 | IGF1R | 0.51379628 |
| 113 | STK38 | 0.50287006 |
| 114 | PRKD2 | 0.49731484 |
| 115 | CSK | 0.48510867 |
| 116 | TRPM7 | 0.47547359 |
| 117 | UHMK1 | 0.47516438 |
| 118 | IRAK2 | 0.47465280 |
| 119 | AKT3 | 0.46532249 |
| 120 | DMPK | 0.44826487 |
| 121 | PRKCQ | 0.44390122 |
| 122 | MAP4K2 | 0.43031515 |
| 123 | MET | 0.42876080 |
| 124 | PRKAA1 | 0.42688297 |
| 125 | MAP2K6 | 0.42528063 |
| 126 | CAMK1D | 0.42342359 |
| 127 | ADRBK2 | 0.42199439 |
| 128 | PRKCH | 0.40966422 |
| 129 | STK38L | 0.38296901 |
| 130 | LYN | 0.35623706 |
| 131 | MATK | 0.35507490 |
| 132 | PRKACG | 0.33529193 |
| 133 | CHUK | 0.33152852 |
| 134 | ZAK | 0.30825601 |
| 135 | PAK3 | 0.30777660 |
| 136 | GSK3A | 0.29187092 |
| 137 | MAP3K7 | 0.28758983 |
| 138 | CSF1R | 0.28651386 |
| 139 | ABL2 | 0.27663753 |
| 140 | ITK | 0.27485117 |
| 141 | RET | 0.26508452 |
| 142 | NTRK1 | 0.25984953 |
| 143 | PRKCE | 0.25449753 |
| 144 | PHKG2 | 0.25126492 |
| 145 | PHKG1 | 0.25126492 |
| 146 | WNK1 | 0.23543272 |
| 147 | IKBKB | 0.23183691 |
| 148 | GRK7 | 0.22268799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.13244301 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31555963 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.84657009 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.82639486 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72148333 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71084908 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.63156023 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52562590 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27509515 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.23861535 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.20590391 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14515593 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10337427 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.02512635 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94418990 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.93896131 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93117852 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87283545 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84789807 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.83553800 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82785793 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.81827591 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.80576610 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77751035 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77670566 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72787505 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66460629 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64976811 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.62719727 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.61570233 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.59685512 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57388742 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54030695 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52395595 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49336826 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48175037 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47476270 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47186184 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46460152 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44652065 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.44516020 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44298704 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.43136419 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.41406858 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41003467 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.40784035 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36731837 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35615142 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35558222 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33795801 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 1.32454972 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.32123387 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31925354 |
| 54 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29715884 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.28331492 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26112425 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24240156 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.23628264 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21078953 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19388495 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16775679 |
| 62 | Bile secretion_Homo sapiens_hsa04976 | 1.16255704 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14684473 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07543748 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05742142 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04991455 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03956393 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02282808 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02122448 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00065738 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99075817 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98616610 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.98062451 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97634782 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96859375 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.95729915 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95435233 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94576284 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.92962063 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92164798 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91553350 |
| 82 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90164557 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89667957 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87885274 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87395777 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86940673 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86342346 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85810124 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.84617730 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83720765 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81766984 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81032743 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80514552 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78562619 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74351439 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72975136 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72235229 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72217450 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72060265 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71957845 |
| 101 | Influenza A_Homo sapiens_hsa05164 | 0.70566978 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70220844 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69135230 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68001984 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66054602 |
| 106 | Measles_Homo sapiens_hsa05162 | 0.65752947 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65572668 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65344201 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.63652261 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.62778545 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61307349 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.58263324 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.58199234 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57868731 |
| 115 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56952116 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56441365 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56200195 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55562445 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54226347 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53885438 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.53796419 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53496474 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.53412605 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53178865 |
| 125 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52737775 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51704465 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51375691 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50810493 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.50743505 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48181484 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47678365 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47180968 |
| 133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46712926 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46180517 |
| 135 | Prion diseases_Homo sapiens_hsa05020 | 0.45849371 |
| 136 | Insulin secretion_Homo sapiens_hsa04911 | 0.45833344 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44575022 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.43072123 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42245960 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40293058 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39998115 |
| 142 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38294031 |
| 143 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37899581 |
| 144 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35759905 |
| 145 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34444699 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33014856 |
| 147 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31012333 |
| 148 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30878050 |
| 149 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29992361 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27067545 |
| 151 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23248400 |
| 152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19216123 |
| 153 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19159722 |
| 154 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16658105 |
| 155 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15963760 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14153813 |
| 157 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14016303 |
| 158 | Legionellosis_Homo sapiens_hsa05134 | 0.11650584 |
| 159 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11061484 |
| 160 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10331947 |

